Metoprolol Succinate | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Metoprolol Succinate
Health Canada Patents

PharmaCompass Sponsored Ads

Contact Supplier

Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

Contact Supplier

xyz-pharma-m-2025-03-24

Contact Supplier

LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

Contact Supplier

Gentec Pharmaceutical Group is focused on manufacturing & developing APIs/HPAPIs, Advanced Intermediates & Fine Chemicals.

Contact Supplier

xyz-pharma-m-2025-03-17

Contact Supplier

Metoprolol Succinate

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

52 API Suppliers, 34 USDMF, 17 CEP/COS, 13 EU WC, 17 NDC API, 27 Listed Suppliers, $ API Reference Price

52 API Suppliers
34 USDMF
17 CEP/COS
13 EU WC
17 NDC API
27 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

3 Drugs in Development

3 Drugs in Development

INTERMEDIATES

5 Intermediate Suppliers

5 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

189 FDF Dossiers, 95 FDA Orange Book, 30 Europe, 27 Australia, 37 Listed Dossiers

189 FDF Dossiers
95 FDA Orange Book
30 Europe
27 Australia
37 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET, EXTENDED RELEASE;ORAL - EQ 100MG TARTRATE, TABLET, EXTENDED RELEASE;ORAL - EQ 200MG TARTRATE, TABLET, EXTENDED RELEASE;ORAL - EQ 25MG TARTRATE, TABLET, EXTENDED RELEASE;ORAL - EQ 50MG TARTRATE, CAPSULE, EXTENDED RELEASE;ORAL - EQ 100MG TARTRATE, CAPSULE, EXTENDED RELEASE;ORAL - EQ 200MG TARTRATE, CAPSULE, EXTENDED RELEASE;ORAL - EQ 25MG TARTRATE, CAPSULE, EXTENDED RELEASE;ORAL - EQ 50MG TARTRATE, TABLET, EXTENDED RELEASE;ORAL - 12.5MG;EQ 100MG TARTRATE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - 12.5MG;EQ 25MG TARTRATE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - 12.5MG;EQ 50MG TARTRATE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET, EXTENDED RELEASE;ORAL - EQ 100MG TARTRATE
TABLET, EXTENDED RELEASE;ORAL - EQ 200MG TARTRATE
TABLET, EXTENDED RELEASE;ORAL - EQ 25MG TARTRATE
TABLET, EXTENDED RELEASE;ORAL - EQ 50MG TARTRATE
CAPSULE, EXTENDED RELEASE;ORAL - EQ 100MG TARTRATE
CAPSULE, EXTENDED RELEASE;ORAL - EQ 200MG TARTRATE
CAPSULE, EXTENDED RELEASE;ORAL - EQ 25MG TARTRATE
CAPSULE, EXTENDED RELEASE;ORAL - EQ 50MG TARTRATE
TABLET, EXTENDED RELEASE;ORAL - 12.5MG;EQ 100MG TARTRATE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET, EXTENDED RELEASE;ORAL - 12.5MG;EQ 25MG TARTRATE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET, EXTENDED RELEASE;ORAL - 12.5MG;EQ 50MG TARTRATE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Minakem, 6 Evonik, 2 Rochem International Inc, 6 SPI Pharma, 13 DKSH, 6 Faran Shimi Pharmaceutical, 5 Boai NKY Pharmaceuticals Ltd, 1 Chynops Pharma, 5 Gangwal Healthcare, 7 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 1 Pramukh Pharmachem, 1 Zeal MediPharma, 4 ACG Worldwide, 7 Actylis, 1 Aeon Procare, 3 Alcedo Pharmachem, 9 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 30 BASF, 1 Clariant, 15 Corel Pharma Chem, 5 DFE Pharma, 2 Finar, 12 Gangwal Chemicals, 13 Ideal Cures Pvt Ltd, 3 Ingredion Pharma Solutions, 32 Kerry, 5 Kima Chemical, 6 Lonza Capsugel, 17 Microlex e.U, 2 Nanjing Bold Chemical, 1 NEWEDGE Overseas, 2 Nomisma Healthcare, 3 Novo Excipients, 4 Pharmatrans-Sanaq, 6 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 21 Roquette, 14 Seppic, 6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 11 Sigachi Industries, 4 The Dow Chemical Company, 1 Ulanqab Kema New Material, 2 Valens Pharmachem, 4 Vasa Pharmachem, 2 Vertellus

EXCIPIENTS BY APPLICATIONS

76 Fillers, Diluents & Binders, 73 Coating Systems & Additives, 43 Controlled & Modified Release, 41 Thickeners and Stabilizers, 38 Solubilizers, 32 Disintegrants & Superdisintegrants, 29 Direct Compression, 27 Granulation, 23 Lubricants & Glidants, 23 Film Formers & Plasticizers, 17 Topical, 16 Taste Masking, 13 Co-Processed Excipients, 12 Parenteral, 11 Rheology Modifiers, 11 Chewable & Orodispersible Aids, 9 Empty Capsules, 9 Emulsifying Agents, 5 API Stability Enhancers, 5 Coloring Agents, 4 Vegetarian Capsules, 4 Surfactant & Foaming Agents

76 Fillers, Diluents & Binders
73 Coating Systems & Additives
43 Controlled & Modified Release
41 Thickeners and Stabilizers
38 Solubilizers
32 Disintegrants & Superdisintegrants
29 Direct Compression
27 Granulation
23 Lubricants & Glidants
23 Film Formers & Plasticizers
17 Topical
16 Taste Masking
13 Co-Processed Excipients
12 Parenteral
11 Rheology Modifiers
11 Chewable & Orodispersible Aids
9 Empty Capsules
9 Emulsifying Agents
5 API Stability Enhancers
5 Coloring Agents
4 Vegetarian Capsules
4 Surfactant & Foaming Agents

DIGITAL CONTENT

32 News #PharmaBuzz

32 News #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 12 Regulatory FDF Prices

2 US Medicaid Prescriptions
12 Regulatory FDF Prices

MARKET PLACE

9 APIs, 1 FDF Dossiers

9 APIs
1 FDF Dossiers

PATENTS & EXCLUSIVITIES

8 US Patents, 3 Health Canada Patents

8 US Patents
3 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 EDQM, 1 USP, 1 Others

2 EDQM
1 USP
1 Others

$ API Ref.Price (USD/KG) : 46 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

3 All

01 3Blank

filter Patent Reset all filters

3 All

01 31293449

filter Product Reset all filters

3 All

01 3Blank

filter Dosage Reset all filters

3 All

01 3Blank

filter Exp Date Reset all filters

3 All

01 32008-12-24

Granules Metoprolol Succinate

Product Main Page

01

Metoprolol Succinate

ASPEN

Not Confirmed

Country

ASPEN

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2008-12-24

Date Granted :

Metoprolol Succinate

Brand Name :

Patent Number : 1293449

Filing Date :

Strength per Unit :

Dosage Form :

Human Or VET :

Route of Administration :

Patent Expiration Date : 2008-12-24

Date Granted :

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

02

Metoprolol Succinate

ASPEN

Not Confirmed

Country

ASPEN

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2008-12-24

Date Granted :

Metoprolol Succinate

Brand Name :

Patent Number : 1293449

Filing Date :

Strength per Unit :

Dosage Form :

Human Or VET :

Route of Administration :

Patent Expiration Date : 2008-12-24

Date Granted :

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

03

Metoprolol Succinate

ASPEN

Not Confirmed

Country

ASPEN

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2008-12-24

Date Granted :

Metoprolol Succinate

Brand Name :

Patent Number : 1293449

Filing Date :

Strength per Unit :

Dosage Form :

Human Or VET :

Route of Administration :

Patent Expiration Date : 2008-12-24

Date Granted :

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!